Data as of 2:23pm ET
| -0.02 / -1.29%|
The 1 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +30.72% increase from the last price of 1.53.
The current consensus among 1 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.